SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-014582
Filing Date
2023-05-15
Accepted
2023-05-15 16:18:10
Documents
47
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q rvph20230331_10q.htm   iXBRL 10-Q 577394
2 EXHIBIT 31.1 ex_512586.htm EX-31.1 12233
3 EXHIBIT 31.2 ex_512585.htm EX-31.2 12170
4 EXHIBIT 32.1 ex_512587.htm EX-32.1 7758
  Complete submission text file 0001437749-23-014582.txt   3033144

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rvph-20230331.xsd EX-101.SCH 33462
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvph-20230331_def.xml EX-101.DEF 237118
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvph-20230331_lab.xml EX-101.LAB 197989
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvph-20230331_pre.xml EX-101.PRE 250540
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rvph-20230331_cal.xml EX-101.CAL 18082
41 EXTRACTED XBRL INSTANCE DOCUMENT rvph20230331_10q_htm.xml XML 307951
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38634 | Film No.: 23922715
SIC: 2834 Pharmaceutical Preparations